106
Views
5
CrossRef citations to date
0
Altmetric
Original Research

BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo

, , , , , , , , , & show all
Pages 59-70 | Published online: 30 Dec 2015

Figures & data

Figure 1 (A) SEM image and (B) HRTEM image of BCc1.

Note: Scale of A is 500 nm and two yellow particles are 44 nm.
Abbreviations: SEM, scanning electron microscopy; HRTEM, high-resolution transmission electron microscopy.
Figure 1 (A) SEM image and (B) HRTEM image of BCc1.

Figure 2 Infrared spectrum analysis (A) and complexometric titration (B)

Figure 2 Infrared spectrum analysis (A) and complexometric titration (B)

Table 1 IC50 values in neoplastic and normal cells

Figure 3 BCc1 cell toxicity in malignant and normal cells after 24 hours (A) and 48 hours (B).

Note: Significant differences in the control cells have been specified by a single asterisk (*), meaning P-value ≤0.05.
Abbreviation: MEFs, mice embryonic fibroblasts.
Figure 3 BCc1 cell toxicity in malignant and normal cells after 24 hours (A) and 48 hours (B).

Figure 4 The protection of MEF cells from H2O2-induced oxidative toxicity by BCc1.

Notes: Significant differences in the H2O2-treated cells have been specified by a single asterisk (*), meaning P-value ≤0.05. Significant differences in the control cells have been specified by a single hash (#), meaning P-value ≤0.05.
Abbreviation: MEF, mice embryonic fibroblast.
Figure 4 The protection of MEF cells from H2O2-induced oxidative toxicity by BCc1.

Table 2 BCc1 toxicity report

Figure 5 Expression of cell markers CD44 and CD24 in MCF-7 cell line.

Note: The histogram outlined by a black line represents positive staining for CD44 and CD24, and color-filled histograms show negative control stained with matched isotype antibody.
Figure 5 Expression of cell markers CD44 and CD24 in MCF-7 cell line.

Figure 6 Flow cytometry analysis in the control and test after annexin and PI staining.

Abbreviations: PI, propidium iodide; FITC, fluorescein isothiocyanate.
Figure 6 Flow cytometry analysis in the control and test after annexin and PI staining.

Figure 7 Flow cytometry analysis in the control and test for cell cycle analysis.

Figure 7 Flow cytometry analysis in the control and test for cell cycle analysis.

Figure 8 BCc1 tumor suppressing effect (A). Ratio of tumor size on the day 23 in relation to day 1 in the control and test groups (B).

Notes: The tumor size from each group at the end of the experiment (day 23) was divided over the tumor size from each group in the beginning of the treatment (day 1) to demonstrate the efficacy of the nanocomplex in controlling tumor growth by using mathematical logic.
Figure 8 BCc1 tumor suppressing effect (A). Ratio of tumor size on the day 23 in relation to day 1 in the control and test groups (B).

Figure 9 Survival diagrams of the control and test groups.

Figure 9 Survival diagrams of the control and test groups.

Figure 10 The average amounts for Hb concentration (A), RBC count (B), HCT (C), and MCV (D).

Abbreviations: Hb, hemoglobin; RBC, red blood cell; HCT, hematocrit; MCV, mean cell volume.
Figure 10 The average amounts for Hb concentration (A), RBC count (B), HCT (C), and MCV (D).

Figure 11 Hematoxylin and eosin staining of (A) normal lung tissue, (B) clumps of metastatic tumor cells, (C) normal liver tissue, (D) clumps of metastatic cells, and (E) the megakaryocyte within the liver sinusoids.

Figure 11 Hematoxylin and eosin staining of (A) normal lung tissue, (B) clumps of metastatic tumor cells, (C) normal liver tissue, (D) clumps of metastatic cells, and (E) the megakaryocyte within the liver sinusoids.